Perspective Therapeutics, Inc. — Director's Dealing 2018

Nov 15, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2018-11-13

Reporting Person: Austin Mark John (Controller/Prin Fin&Acct Offic)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-13	Common Stock	P	2452	$0.41	Acquired	11717	Direct